Related Experiment Video

Updated: Feb 24, 2026

Frailty Assessment in an Aging Mouse Model
06:58

Frailty Assessment in an Aging Mouse Model

Published on: September 23, 2025

685

The Fragility Index in a Cohort of Pediatric Randomized Controlled Trials

Travis J Matics1, Nadia Khan2, Priti Jani3

  • 1Department of Pediatrics, Section of Critical Care Medicine, The University of Chicago Medicine, Chicago, IL 60637, USA. travis.matics@uchospitals.edu.

Journal of Clinical Medicine
|August 15, 2017
PubMed

Insights

The Fragility Index helps assess statistical significance in pediatric randomized controlled trials (RCTs). Many studies show results could be overturned by even a few lost patients, highlighting the need for this metric in clinical trial interpretation.

Area of Science:

  • Pediatric clinical trials
  • Statistical analysis in medicine
  • Evidence-based medicine

Background:

  • Traditional statistical methods may not adequately report clinical trial outcomes.
  • The Fragility Index offers a measure of statistical significance's sensitivity to outcome events.
  • Better interpretation of trial results is needed, especially in pediatric research.

Purpose of the Study:

  • To evaluate the Fragility Index in pediatric randomized controlled trials (RCTs) with statistically significant findings.
  • To assess the relationship between trial characteristics and the Fragility Index.
  • To determine the clinical relevance of statistically significant outcomes in pediatric RCTs.

Main Methods:

  • Calculation of the Fragility Index for included pediatric RCTs with dichotomous positive outcomes.
  • Analysis of correlations between trial characteristics (sample size, event group size, p-value) and the Fragility Index.
  • Screening of 429 abstracts to identify 17 eligible trials for analysis.

Main Results:

  • The median Fragility Index was 7 (IQR 2-11).
  • In 41% of studies, patient loss to follow-up equaled or exceeded the Fragility Index.
  • No correlation was found between sample size or event group size and the Fragility Index, but a strong negative correlation existed with the p-value (r = -0.700, p = 0.002).

Conclusions:

  • The Fragility Index is a valuable metric for assessing the robustness of statistically significant findings in pediatric RCTs.
  • Results suggest that statistical significance in some pediatric trials may be fragile and susceptible to patient attrition.
  • The Fragility Index can aid in applying clinical relevance to statistical outcomes in pediatric research.

Keywords:
clinical trialspediatricsrandomized controlled trialsresearch methodologystatistics

More Related Videos

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles04:00

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles

Published on: July 26, 2024

1.4K
A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

930

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
329
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
359
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
286
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
500
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
375
Therapeutic Index01:13

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
7.1K